EXPD vs SRNE · P/E 26, rev $10.60B vs $385.9K cap
Expeditors International of Washington, Inc. (EXPD) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
SRNE does not have a complete income-statement cache yet.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the EXPD and SRNE stock pages for the full models.
Not investment advice.